Radiumhospitalet

September 22, 2022/in AIM, Global, Norway

/wp-content/uploads/Kura_Logo_2024_RGB.svg 0 0 eallison /wp-content/uploads/Kura_Logo_2024_RGB.svg eallison2022-09-22 15:20:302022-09-22 15:20:30Radiumhospitalet

About Us
Our Commitment
The Story Behind Our Name
Leadership
Board of Directors
Grants & Funding
Investigator Sponsored Studies
Compliance Declaration

Our Approach
Precision Medicines
Overcoming Resistance
Novel Biomarkers

Pipeline
Menin Inhibition
Farnesyl Transferase Inhibitors
Posters and Presentations
Scientific Manuscripts
Access to Investigational Drugs Outside a Clinical Study

Patients & Caregivers
Acute Leukemias
Head & Neck Cancer

Our Medicine

Investors
Overview
Press Releases
Events & Presentations
Corporate Governance
Financial Information
Analyst Coverage
FAQs
Contact

Careers
Values
Life at Kura
Benefits
Open Positions

News & Media
Press Releases
News & Perspectives
Expert Perspectives
Media Resources

Contact

Kura Oncology, Inc.
4930 Directors Place, Suite 500
San Diego, CA 92121
(858) 500-8800

Kura Oncology, Inc.
2 Seaport Lane, Suite 8A
Boston, MA 02210
(617) 588-3755

Scroll to top